313 related articles for article (PubMed ID: 29579760)
1. Genetics of Lithium Response in Bipolar Disorder.
Papiol S; Schulze TG; Alda M
Pharmacopsychiatry; 2018 Sep; 51(5):206-211. PubMed ID: 29579760
[TBL] [Abstract][Full Text] [Related]
2. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
3. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
4. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.
Alda M
Mol Psychiatry; 2015 Jun; 20(6):661-70. PubMed ID: 25687772
[TBL] [Abstract][Full Text] [Related]
5. Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.
Mamdani F; Jaitovich Groisman I; Alda M; Turecki G
Curr Psychiatry Rep; 2003 Dec; 5(6):484-92. PubMed ID: 14609504
[TBL] [Abstract][Full Text] [Related]
6. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice.
Coryell W
Bipolar Disord; 2009 Jun; 11 Suppl 2():77-83. PubMed ID: 19538687
[TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of lithium's efficacy and effectiveness: the last 60 years.
Grof P; Müller-Oerlinghausen B
Bipolar Disord; 2009 Jun; 11 Suppl 2():10-9. PubMed ID: 19538682
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of lithium response in bipolar disorder.
Alda M
J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms.
Serretti A; Drago A
Neuropsychobiology; 2010; 62(1):61-71. PubMed ID: 20453536
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Effectiveness of Lithium in the Long-Term Treatment of Bipolar Disorders: An Update 2018.
Severus E; Bauer M; Geddes J
Pharmacopsychiatry; 2018 Sep; 51(5):173-176. PubMed ID: 29898463
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
Malhi GS; Outhred T
CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
[TBL] [Abstract][Full Text] [Related]
12. Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study.
Öhlund L; Ott M; Oja S; Bergqvist M; Lundqvist R; Sandlund M; Salander Renberg E; Werneke U
BMC Psychiatry; 2018 Feb; 18(1):37. PubMed ID: 29415689
[TBL] [Abstract][Full Text] [Related]
13. A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Takeda M; Kunugi H; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):204-8. PubMed ID: 17822820
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study.
Tsermpini EE; Zhang Y; Niola P; Chillotti C; Ardau R; Bocchetta A; Patrinos GP; Del Zompo M; Severino G; Lee MT; Squassina A
Neurosci Lett; 2017 Jan; 638():1-4. PubMed ID: 27923663
[TBL] [Abstract][Full Text] [Related]
15. Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.
Pavuluri MN; Lee MS; Pandey G
Bipolar Disord; 2015 Mar; 17(2):224-32. PubMed ID: 25523965
[No Abstract] [Full Text] [Related]
16. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.
Schulze TG; Alda M; Adli M; Akula N; Ardau R; Bui ET; Chillotti C; Cichon S; Czerski P; Del Zompo M; Detera-Wadleigh SD; Grof P; Gruber O; Hashimoto R; Hauser J; Hoban R; Iwata N; Kassem L; Kato T; Kittel-Schneider S; Kliwicki S; Kelsoe JR; Kusumi I; Laje G; Leckband SG; Manchia M; Macqueen G; Masui T; Ozaki N; Perlis RH; Pfennig A; Piccardi P; Richardson S; Rouleau G; Reif A; Rybakowski JK; Sasse J; Schumacher J; Severino G; Smoller JW; Squassina A; Turecki G; Young LT; Yoshikawa T; Bauer M; McMahon FJ
Neuropsychobiology; 2010; 62(1):72-8. PubMed ID: 20453537
[TBL] [Abstract][Full Text] [Related]
17. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.
Washizuka S; Ikeda A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):421-4. PubMed ID: 14604458
[TBL] [Abstract][Full Text] [Related]
18. Lithium for bipolar disorder: a review of the recent literature.
Curran G; Ravindran A
Expert Rev Neurother; 2014 Sep; 14(9):1079-98. PubMed ID: 25130062
[TBL] [Abstract][Full Text] [Related]
19. Letter to the editor regarding "A critical appraisal of lithium's efficacy and effectiveness: the last 60 years".
Post RM
Bipolar Disord; 2010 Jun; 12(4):455-6; author reply 457-8. PubMed ID: 20636646
[No Abstract] [Full Text] [Related]
20. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
